Evolution of hepatitis B virus precore/basal core promoter gene in HBeAg-positive chronic hepatitis B patients receiving lamivudine therapy. [electronic resource]
- Liver international : official journal of the International Association for the Study of the Liver Feb 2004
- 9-15 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1478-3223
10.1111/j.1478-3231.2004.00893.x doi
Adult Antiviral Agents--pharmacology DNA-Directed DNA Polymerase--drug effects Female Hepatitis B Core Antigens--drug effects Hepatitis B e Antigens--genetics Hepatitis B virus--drug effects Hepatitis B, Chronic--drug therapy Humans Lamivudine--pharmacology Male Middle Aged Mutation--drug effects Promoter Regions, Genetic--drug effects Virus Replication--drug effects